Cat. #162212
Anti-rGFAP PAb
Cat. #: 162212
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: glial fibrillary acidic protein GFAP
Class: Polyclonal
Application: WB ; IP ; IHC
Reactivity: Human
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Roy Quinlan
Institute: University of Durham
Primary Citation: J E Ralton, et al. 1994. J Cell Sci. 107 ( Pt 7):1935-48. PMID: 7983160.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-rGFAP PAb
- Alternate name: GFAP
- Research fields: Cell biology
- Tool sub type: Primary antibody
- Class: Polyclonal
- Conjugation: Unconjugated
- Molecular weight: 51kDa, 432 residues
- Reactivity: Human
- Application: WB ; IP ; IHC
- Description: Polyclonal antibody specific for GFAP, an intermediate filament protein important in chaperone mediated autophagy and cytoskeletal function. This polyclonal antibody will likely detect all splice variants.
- Immunogen: recombinant human GFAP
- Isotype: IgG
- Recommended controls: astrocytoma cytoskeletal extract from U343MG/U373MG or a spinal cord extract
Target Details
- Target: glial fibrillary acidic protein GFAP
- Target alternate names: GFAP
- Molecular weight: 51kDa, 432 residues
- Target background: GFAP is an intermediate filament that is expressed in astrocytes. Intermediate filaments are a distinct group of cytoskeletal molecules.
Applications
- Application: WB ; IP ; IHC
Handling
- Format: Liquid
- Concentration: 1mg/ml
- Unit size: 100 ug
- Storage buffer: Serum plus azide (0.02%)
- Storage conditions: -80° C
- Shipping conditions: Dry ice
